Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAmortization - GoodwillDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables RefundsShares RepurchasedShort-Term Debt repayments
Ratios

Pediatrix Medical (MD) Receivables - Net (2016 - 2025)

Pediatrix Medical (MD) has disclosed Receivables - Net for 17 consecutive years, with $229.7 million as the latest value for Q4 2025.

  • On a quarterly basis, Receivables - Net fell 11.66% to $229.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $229.7 million, a 11.66% decrease, with the full-year FY2025 number at $229.7 million, down 11.66% from a year prior.
  • Receivables - Net was $229.7 million for Q4 2025 at Pediatrix Medical, down from $231.1 million in the prior quarter.
  • In the past five years, Receivables - Net ranged from a high of $1.5 billion in Q4 2022 to a low of $229.7 million in Q4 2025.
  • A 5-year average of $699.8 million and a median of $298.1 million in 2021 define the central range for Receivables - Net.
  • Peak YoY movement for Receivables - Net: soared 429.9% in 2024, then tumbled 84.27% in 2025.
  • Pediatrix Medical's Receivables - Net stood at $301.8 million in 2021, then soared by 413.13% to $1.5 billion in 2022, then fell by 10.93% to $1.4 billion in 2023, then plummeted by 81.15% to $260.0 million in 2024, then fell by 11.66% to $229.7 million in 2025.
  • Per Business Quant, the three most recent readings for MD's Receivables - Net are $229.7 million (Q4 2025), $231.1 million (Q3 2025), and $239.0 million (Q2 2025).